Notice Title

Consent to the Distribution of a New Medicine

Publication Date
19 Jun 2025

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2025-go3281
Title
View PDF
File Type and Size
PDF (34 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of a new medicine which is referred to the Minister of Health under the provisions of section 24(5) of the Act and it is set out in the Schedule hereto:

Schedule

Product: Alcaine
Active Ingredient: Proxymetacaine hydrochloride 5mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: Alcon Laboratories (New Zealand) Limited
Manufacturers: Novartis Manufacturing NV, Puurs-Sint-Amands, Belgium
Alcon Research LLC, Texas, United States of America


Dated this 17th day of June 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).